2015 AVAHO Conference Program

Transcription

1 2015 AVAHO Conference Program Precision & Personalized Medicine Their role in Hematologic-Oncologic Care within VHA Friday, October 2 6:00 6:10 Introduction 6:10 7:10 Keynote Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, MD, PhD Director, National Genome Research Institute National Institute of Health Bethesda, MD 7:10 7:45 Reception (Cash bar) Dinner on own Saturday, October 3 Breakfast on own 8:00 9:30 General Session I Determining the Most Appropriate Care Can Precision Medicine Help? Incorporating value into oncologic care with precision medicine Robert Nussbaum, MD Clinical Professor, UCSF Director, Invitae San Francisco, CA Pharmacogenomics Ensuring the treatment fits the patient Richard Weinshilbourn, MD Division of Clinical Pharmacology Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic Rochester, MN

2 8:00 9:30 General Session IA Tumor Registrar Workshop Coding tips and shortcuts: Part 1 James Hofferkamp, BA CTR Trainer North American Association of Central Cancer Registries Springfield, IL 9:30 10:00 Coffee 10:00 11:45 General Session II The Financial Impact of Precision Medicine The challenges of precision medicine: new advances in molecular diagnostic testing impact for VHA Jessica Wang-Rodriguez, MD Chief, Pathology and Laboratory Medicine Translational Oncology Program VA San Diego Health Care System San Diego, CA Targeted oncology drug cost considerations A pharmacy perspective Brian Dahl, Pharm D Oncology Pharmacist VA San Diego Health Care System San Diego, CA Strategies to decrease cost of precision medicine for CML? Neal Shah, MD Associate Professor UCSF School of Medicine San Francisco, CA

3 10:00 11:45 General Session IIA Tumor Registrar Workshop Coding tips and shortcuts: Part 2 James Hofferkamp, BA CTR Trainer North American Association of Central Cancer Registries Springfield, IL 12:00 1:20 Lunch & Business Meeting AVAHO members only 1:30 3:00 Breakout Sessions 1 Attendees choose one of the following (A,B,C,D) Session A: Survivorship Issues Maintaining Wellness The Impact of Obesity on Cancer Recovery Wendy Demark-Wahnefried, PhD, RD Professor and Chair, Nutrition Sciences University of Alabama, Birmingham Associate Director for Cancer Prevention and Control UAB Comprehensive Cancer Center Birmingham, AL Mindfulness Kate Adelstein, MSN, ANP-BC, PhD Candidate School of Nursing University of Virginia Richmond, VA Session B: Dealing with Concurrent Cognitive and Emotional Challenges PTSD in cancer Focus on hypervigilance and avoidance behaviors Matthew Cordova, PHD Associate Professor Palo Alto University Clinical Psychologist VA Northern California Health Care System Martinez, CA

4 Chemo Brain The cognitive challenges associated with cancer and treatment Michelle Janelsins-Benton, PhD Assistant Professor Department of Surgery, Cancer Control University of Rochester Rochester, New York Session C - Precision Medicine in Lung Cancer: Impact in Diagnosis, Imaging, and Pharmacologic Therapy Targeted approaches in establishing diagnosis and prognosis James Herman, MD, MSPH Professor of Medicine, Co-Leader, UPCI Lung Cancer Program University of Pittsburgh Pittsburgh, PA Targeted therapy in lung cancer Corey J. Langer, MD Director, Thoracic Oncology Abramson Cancer Center Professor of Medicine University of Pennsylvania Philadelphia, PA Using Big Data to achieve precision/personalized screening and diagnosis in lung cancer: The next generation Eliot L Siegel, MD Associate Vice Chair Diagnostic Radiology and Nuclear Medicine University of Maryland Chief of Imaging VA Maryland Health Care System Baltimore, MD

5 Session D - Role of Precision Medicine in Federal Programs The role of precision medicine in clinical trial design and drug approval Nicole Gormley, MD Division of Hematology Products Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring, MD VHA Precision Oncology Program Louis Fiore, MD, MPH Executive Director, MAVERIC VA Boston Health Care System Boston, MA 3:00 3:30 Coffee 3:30 5:00 Breakout Sessions 2 (Repeat of above) (Attendees choose one) 5:00 6:00 Small Group Discussions (Attendees choose one) APRN/PA COC Accreditation Nursing Pharmacy Radiation Oncology Research/Clinical Trials Social Work 6:00 7:15 Poster Session 7:15 8:15 Dinner & Presidential Address João Ascensão, MD, PhD, FACP Chief, Hematology VAMC, Washington D.C. President, AVAHO

6 8:15 9:15 Keynote The Personal Side of Personalized Medicine Betty Ferrell, PhD, MA, FAAN, FPCN Director and Professor, Nursing Research and Education Associate Director for Nursing Research City of Hope, Duarte, CA Sunday, October 4 7:30 9:30 Oral Abstract Session 7:30 7:50 Biochemical alterations in BRAF Inhibitor resistant melanoma cells increase their vulnerability to arginine deprivation Li YY, Wu CJ, Chen SM, Wangpaichitr M, Feun LG, Kuo MT, Savaraj N Miami VA, Miami FL 7:50 8:10 Creating a safety net: A model for addressing needs of veterans who travel for cancer care using patient navigation Slind LM, Keating TM, Rose TG VA Puget Sound, Seattle WA 8:10 8:30 Impact of demographic and health system variables on survival in early stage (stage I and II) non-small cell lung carcinoma: A national cancer database analysis Goyal G, Nawal L, Monirul Islam KM, Silberstein PT, Ganti AK Omaha VAMC, Omaha NB 8:30 8:50 Measuring symptoms in veterans receiving care in a hematologyoncology clinic using the veteran symptom assessment scale (VSAS) Boyle R, Hamilton-Hill S, Nason E, Kelley M, Friedman D Durham VAMC, Durham NC 8:50 9:10 Ketogenic diet in advanced cancer: Final results of a safety and feasibility study Tan-Shalaby J, Carrick J, Edinger K, Liman A, Passero V, Shah R Pittsburgh VAMC, Pittsburgh, PA 9:10 9:30 Implementation of NCCN s guidelines for inherited polyposis: The VA genomic medicine service experience Hartzfeld D, Lynch J, Dunn K Salt Lake City VAMC, Salt Lake, UT

7 9:30 9:50 Coffee 9:50 11:35 General Sessions III Difficult Conversations An Important Aspect of Personalized Medicine Discussing prognosis Tomer Levin, MD Department of Psychiatry and Behavioral Sciences Memorial Sloan-Kettering Cancer Center New York, New York Disease progression: Maintaining hope in the context of reality Charles von Gunten, MD, PhD Vice President, Medical Affairs Hospice and Palliative Medicine Ohio Health Columbus, OH End of life planning How to time this in the context of active treatment Kelly Artis, MSW Hospice Palliative Care Social Worker Kansas City VA Medical Center Kansas City, MO 11:35 12:15 Keynote TBD 12:15 12:30 Adjourn Anita Aggarwal, DO, PhD Hematology/Oncology VA Medical Center, Washington DC President, AVAHO 2016